NEW YORK, Nov. 22, 2011 /PRNewswire/ --Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Chemed Corp. ("Chemed" or the "Company") (NYSE: CHE) concerning possible violations of federal securities laws.
For more information, click here: http://zlk.9nl.com/chemed-che.
The investigation stems from allegations that Chemed defrauded Medicare and Medicaid out of millions of dollars by admitting non-terminal patients into hospices. The accusation was leveled in a complaint filed on behalf of Michael Rehfeldt, a former Vitas Healthcare Corp manager. Upon news of these allegations, shares of Chemed fell approximately 12 percent to close at $50.65.
If you own Chemed stock and wish to obtain additional information about the investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/chemed-che.html.
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
